1. Sensing Bacterial-Induced DNA Damaging Effects via Natural Killer Group 2 Member D Immune Receptor: From Dysbiosis to Autoimmunity and Carcinogenesis
   J. Luis Espinoza et al, 2018, Frontiers in Immunology CrossRef
2. γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?
   Jaydeep Bhat et al, 2015, OncoImmunology CrossRef
3. Glycosyl-Phosphatidyl-Inositol (GPI)-Anchors and Metalloproteases: Their Roles in the Regulation of Exosome Composition and NKG2D-Mediated Immune Recognition
   Sheila López-Cobo et al, 2016, Frontiers in Cell and Developmental Biology CrossRef
4. Role of the Main Non HLA-Specific Activating NK Receptors in Pancreatic, Colorectal and Gastric Tumors Surveillance
   Elisa Ferretti et al, 2020, Cancers CrossRef
5. Epigenetic modulation and prostate cancer: Paving the way for NK cell anti-tumor immunity
   Filipa D. dos Reis et al, 2023, Frontiers in Immunology CrossRef
6. Epigenetic induction of CD1d expression primes lung cancer cells for killing by invariant natural killer T cells
   Éilis Dockry et al, 2018, OncoImmunology CrossRef
7. Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer
   Timm Hoeres et al, 2018, Frontiers in Immunology CrossRef
8. Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma
   Guo-Tian Ruan et al, 2021, Aging CrossRef
9. Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
   Rodolfo Soria-Castro et al, 2019, Journal of Immunology Research CrossRef